RecruitingNot applicableNCT01633489
Lysosomal Acid Lipase (LAL) Deficiency Registry
Studying Lysosomal acid lipase deficiency
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Alexion Pharmaceuticals, Inc.
- Principal Investigator
- Alexion PharmaceuticalsSponsor GmbH
- Enrollment
- 300 enrolled
- Eligibility
- All sexes
- Timeline
- 2013 – 2029
Study locations (17)
- Clinical Trial Site, Phoenix, Arizona, United States
- Clinical Trial Site, Stanford, California, United States
- Clinical Trial Site, Miramar, Florida, United States
- Clinical Trial Site, Orlando, Florida, United States
- Clinical Trial Site, Atlanta, Georgia, United States
- Clinical Trial Site, Chicago, Illinois, United States
- Clinical Trial Site, Boston, Massachusetts, United States
- Clinical Trial Site, Detroit, Michigan, United States
- Clinical Trial Site, Minneapolis, Minnesota, United States
- Clinical Trial Site, Jackson, Mississippi, United States
- Clinical Trial Site, Hackensack, NJ, 7601, New Jersey, United States
- Clinical Trial Site, New York, New York, United States
- Clinical Trial Site, The Bronx, New York, United States
- Clinical Trial Site, Philadelphia, Pennsylvania, United States
- Clinical Trial Site, Houston, Texas, United States
- +2 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01633489 on ClinicalTrials.govOther trials for Lysosomal acid lipase deficiency
Additional recruiting or active studies for the same condition.